Clinical Trial Update: Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the effect of secukinumab on radiographic progression in Ankylosing Spondylitis vs an adalimumab biosimilar (GP2017) completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• GP2017 (adalimumab)
• Secukinumab (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2023-03-09